CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Kaj BlennowDaniela Diaz-LucenaHenrik ZetterbergAnna Villar-PiqueAndre KarchEnric VidalPeter HermannMatthias SchmitzIsidro Ferrer AbizandaInga ZerrFranc LlorensPublished in: Journal of neurology, neurosurgery, and psychiatry (2019)
Neurogranin is a new biomarker of prion pathogenesis with diagnostic and prognostic abilities, which reflects the degree of neuronal damage in brain tissue in a CJD subtype manner.